Sanofi Pasteur recently received licensure of Fluzone® High-Dose influenza virus vaccine. The new vaccine is designed to generate better influenza immune response in people 65 year and older. While this age group only accounts for 15% of the US population, they account for 90% of all deaths due to seasonal flu and its complications.

Fluzone pre-booking is well underway, visit https://www.vaccineshoppe.com today.